March Bio has raised over $51 million to date inclusive of all dilutive and non-dilutive funding. The Cancer Focus Fund was among initial investors and parcipated in a second round.

Houston-based scientists, entrepreneurs, clinical centers, manufacturers and investors collaborate to advance promising new approach for patients with few treatment option

The Cancer Focus Fund invested $4.8 million into March Biosciences, a cell therapy company that has already tapped some of Houston’s growing life sciences resources.